Zura Bio Limited (ZURA)
NASDAQ: ZURA · IEX Real-Time Price · USD
3.620
+0.310 (9.37%)
At close: Apr 25, 2024, 4:00 PM
3.780
+0.160 (4.42%)
Pre-market: Apr 26, 2024, 6:32 AM EDT
Zura Bio Market Cap
Zura Bio has a market cap or net worth of $225.62 million as of April 26, 2024. Its market cap has increased by 342.39% in one year.
Market Cap
225.62M
Enterprise Value
125.81M
1-Year Change
342.39%
Ranking
Category
Stock Price
$3.62
Market Cap Chart
Since July 14, 2021, Zura Bio's market cap has increased from $149.30M to $225.62M, an increase of 51.12%. That is a compound annual growth rate of 15.99%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 25, 2024 | 157.80M | 9.36% |
Apr 24, 2024 | 144.30M | -4.88% |
Apr 23, 2024 | 151.70M | 5.13% |
Apr 22, 2024 | 144.30M | - |
Apr 19, 2024 | 144.30M | -10.32% |
Apr 18, 2024 | 160.90M | 17.96% |
Apr 17, 2024 | 136.40M | 2.94% |
Apr 16, 2024 | 132.50M | -3.21% |
Apr 15, 2024 | 136.90M | -6.55% |
Apr 12, 2024 | 146.50M | 17.11% |
Apr 11, 2024 | 125.10M | 3.22% |
Apr 10, 2024 | 121.20M | 0.33% |
Apr 9, 2024 | 120.80M | -0.66% |
Apr 8, 2024 | 121.60M | 2.18% |
Apr 5, 2024 | 119.00M | -5.85% |
Apr 4, 2024 | 126.40M | -1.02% |
Apr 3, 2024 | 127.70M | - |
Apr 2, 2024 | 127.70M | 2.82% |
Apr 1, 2024 | 124.20M | 10.89% |
Mar 28, 2024 | 112.00M | 10.78% |
Mar 27, 2024 | 101.10M | 2.64% |
Mar 26, 2024 | 98.50M | -5.83% |
Mar 25, 2024 | 104.60M | 17.00% |
Mar 22, 2024 | 89.40M | -29.05% |
Mar 21, 2024 | 126.00M | -4.91% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
I-Mab | 149.38M |
ClearPoint Neuro | 148.64M |
Biodesix | 147.77M |
CervoMed | 147.41M |
Augmedix | 145.73M |
Regulus Therapeutics | 144.02M |
Rezolute | 142.05M |
YS Biopharma Co. | 139.55M |